Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

Eli Lilly cuts cash prices for Zepbound weight-loss vials on LillyDirect, offering doses from $299 to $449 as demand for ...

Just this week, the World Health Organization released new guidelines recommending GLP-1 therapies as a long-term treatment for adults with obesity.

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...

As next-generation obesity treatments continue to be developed, the obesity drug market is expected to be restructured next year, centering around ...

Other Indian majors with this development are likely to fast-track their efforts to develop or license generic versions of Semaglutide.